Recoupling of eNOS with folic acid prevents abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E null mice

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Siu, Kin Lung ^a   Miao, Xiao Niu ^a   Cai, Hua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; DIHYDROFOLATE REDUCTASE; ELASTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOLIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SUPEROXIDE; TETRAHYDROBIOPTERIN; BIOPTERIN; SAPROPTERIN;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; ECHOGRAPHY; ELECTRON SPIN RESONANCE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ABDOMINAL AORTA; ANALOGS AND DERIVATIVES; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; DEFICIENCY; DRUG EFFECTS; GENETICS; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; RADIOGRAPHY; VASCULAR REMODELING;

ADMINISTRATION, ORAL; ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; BIOPTERIN; FOLIC ACID; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; SUPEROXIDES; TETRAHYDROFOLATE DEHYDROGENASE; VASCULAR REMODELING;

EID: 84895890025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088899     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999-2010 on CDC WONDER Online Database, released January 2013. Data are compiled from Compressed Mortality File 1999-2010 Series 20 No. 2P, 2013. Available: http://wonder.cdc.gov/cmf-icd10. html. Accessed Jul 13, 2013 12:24:55 PM.
2. Qadura M, Pervaiz F, Harlock JA, Al-Azzoni A, Farrokhyar F, et al. (2013) Mortality and reintervention following elective abdominal aortic aneurysm repair. J Vasc Surg 57: 1676-1683 e1671.
3. Shimizu K, Mitchell RN, Libby P (2006) Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26:987-994. (Pubitemid 43732102)
4. Michel JB, Martin-Ventura JL, Egido J, Sakalihasan N, Treska V, et al. (2011) Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res 90:18-27.
5. Tsuruda T, Kato J, Hatakeyama K, Kojima K, Yano M, et al. (2008) Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm. Circ Res 102:1368-1377.
6. Turner GH, Olzinski AR, Bernard RE, Aravindhan K, Boyle RJ, et al. (2009) Assessment of macrophage infiltration in a murine model of abdominal aortic aneurysm. J Magn Reson Imaging 30:455-460.
7. Gavrila D, Li WG, McCormick ML, Thomas M, Daugherty A, et al. (2005) Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25:1671-1677. (Pubitemid 41098939)
8. Grigoryants V, Hannawa KK, Pearce CG, Sinha I, Roelofs KJ, et al. (2005) Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. J Vasc Surg 41:108-114. (Pubitemid 40197505)
9. Thomas M, Gavrila D, McCormick ML, Miller FJ Jr, Daugherty A, et al. (2006) Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 114:404-413. (Pubitemid 44264822)
10. Xiong W, Mactaggart J, Knispel R, Worth J, Zhu Z, et al. (2009) Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model. Atherosclerosis 202:128-134.
11. Dubick MA, Hunter GC, Casey SM, Keen CL (1987) Aortic ascorbic acid, trace elements, and superoxide dismutase activity in human aneurysmal and occlusive disease. Proc Soc Exp Biol Med 184:138-143. (Pubitemid 17022084)
12. Dubick MA, Keen CL, DiSilvestro RA, Eskelson CD, Ireton J, et al. (1999) Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med 220:39-45.
13. Miller FJ Jr, Sharp WJ, Fang X, Oberley LW, Oberley TD, et al. (2002) Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 22:560-565. (Pubitemid 34408734)
14. Cafueri G, Parodi F, Pistorio A, Bertolotto M, Ventura F, et al. (2012) Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition. PLoS One 7:e35312.
15. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, et al. (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104:448-454. (Pubitemid 32678276)
16. Johanning JM, Franklin DP, Han DC, Carey DJ, Elmore JR (2001) Inhibition of inducible nitric oxide synthase limits nitric oxide production and experimental aneurysm expansion. J Vasc Surg 33:579-586. (Pubitemid 32215609)
17. Fatini C, Sofi F, Sticchi E, Bolli P, Sestini I, et al. (2005) eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysm. J Vasc Surg 42:415-419. (Pubitemid 41323826)
18. Gao L, Siu KL, Chalupsky K, Nguyen A, Chen P, et al. (2011) Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid. Hypertension 59:158-166.
19. Daugherty A, Manning MW, Cassis LA (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105:1605-1612. (Pubitemid 30390311)
20. Satoh K, Nigro P, Matoba T, O'Dell MR, Cui Z, et al. (2009) Cyclophilin A enhances vascular oxidative stress and the development of angiotensin IIinduced aortic aneurysms. Nat Med 15:649-656.
21. Gao L, Chalupsky K, Stefani E, Cai H (2009) Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity. J Mol Cell Cardiol 47:752-760.
22. Tamarat R, Silvestre JS, Kubis N, Benessiano J, Duriez M, et al. (2002) Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension 39:830-835. (Pubitemid 34252885)
23. Yayama K, Hiyoshi H, Imazu D, Okamoto H (2006) Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor. Hypertension 48:958-964. (Pubitemid 44611011)
24. Chalupsky K, Cai H (2005) Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 102:9056-9061. (Pubitemid 40881077)
25. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330:1029-1035.
26. Tornwall ME, Virtamo J, Haukka JK, Albanes D, Huttunen JK (2001) Alpha-tocopherol (vitamin E) and beta-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial. Atherosclerosis 157:167-173. (Pubitemid 32539367)
27. Chen J, Kuhlencordt PJ, Astern J, Gyurko R, Huang PL (2001) Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation 104:2391-2394. (Pubitemid 33108369)
28. Oak JH, Cai H (2007) Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes 56:118-126.
29. Dikalova AE, Gongora MC, Harrison DG, Lambeth JD, Dikalov S, et al. (2010) Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol 299:H673-679.